Global ETF FlowWatch highlights - September 2021

Worldwide ETFs recorded US$60 billion in net flows during September 2021 amid robust investment activity. Equity ETFs led with US$37 billion in net new money, followed by bond ETFs accumulating US$22 billion in net flows. Commodity ETF products trailed behind with US$400 million in net flows. Global ETF assets dropped slightly to US$9.455 trillion as of September 2021.

In the U.S., equity ETF vehicles amassed US$22 billion in net new cash, primarily driven by Equity US - Large Cap accumulating US$16 billion in net subscriptions. Bond ETFs gathered US$12 billion in net new money and commodity ETFs took in US$5 billion in net new cash.

ETFs in Europe gained US$12 billion of net flows, mainly driven by equity and bond ETFs which garnered an aggregate of US$14 billion. This, however, was offset by commodity ETF products suffering nearly US$2 billion in net redemptions. In Asia, equity ETFs received US$5 billion in net new cash, followed by bond ETF investments gathering US$3 billion in net flows. Meanwhile, commodity ETF products experienced net redemptions of US$4 billion. As of September 2021, ETF assets in Europe and Asia stood at US$1.5 and US$1 trillion, respectively.

Fubon Global Genomics and Immuno Biopharma ETF was the largest new ETF launch in September, attracting US$175 million in net flows. The ETF seeks to track the NYSE® FactSet® Global Genomics and Immuno Biopharma Index.